Science
Computational model could improve success in translating drugs from animal studies to humans – Mirage News
Doug Brubaker, a Purdue assistant professor of biomedical engineering, uses computational and experimental approaches to study host-microbiome…
WEST LAFAYETTE, Ind. — About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
Scientists might be able to catch problems like this one earlier in the drug development process, when drugs move from testing in animals to clinical trials, with a new computational model developed by researchers from Purdue University and Massachusetts Institute of Technology.
The researchers call the model “TransCo…
-
Noosa News23 hours agoMan dies after being pulled from surf at Surfers Paradise
-
General24 hours agoNikhil Chaudhary becomes first Indian to score Sheffield Shield century in the 2000s
-
General14 hours agoThe 28-point peace plan for Ukraine mostly contains the same points previously made by Moscow
-
General5 hours agoLabor to squeeze public service, sparking warnings of job losses